日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain

48 个月使用 elagolix 联合补充疗法治疗子宫内膜异位症相关疼痛的安全性

期刊:AJOG Global Reports
影响因子:
doi:10.1016/j.xagr.2025.100584
Kim, Jin Hee; Miller, Charles E; Simon, James A; Thomas, James W; Chan, Anna; Snabes, Michael C
发表日期：2026
文献求助 收藏

Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial

一项为期 60 个月的 3 期临床试验，评估了 elagolix 联合补充疗法对伴有月经过多和子宫肌瘤女性骨密度的影响：开放标签和治疗后结果

期刊:AJOG Global Reports
影响因子:
doi:10.1016/j.xagr.2025.100578
Schnell, Vicki L; Bredeson, Liesl K; Brown, Eric; Chan, Anna; Thomas, James; Simon, James; Snabes, Michael C
发表日期：2025
文献求助 收藏

Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial

睾酮对性腺功能减退男性从糖尿病前期进展为糖尿病的影响：TRAVERSE随机临床试验的子研究

期刊:Jama Internal Medicine
影响因子:23.3
doi:10.1001/jamainternmed.2023.7862
Bhasin, Shalender; Lincoff, A Michael; Nissen, Steven E; Wannemuehler, Kathleen; McDonnell, Marie E; Peters, Anne L; Khan, Nader; Snabes, Michael C; Li, Xue; Li, Geng; Buhr, Kevin; Pencina, Karol M; Travison, Thomas G
代谢
糖尿病
免疫/内分泌
发表日期：2024
文献求助 收藏

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials

人口统计学和临床因素对依拉戈利克斯联合补充疗法治疗伴有月经过多和子宫肌瘤的女性患者自述非出血症状的影响：两项临床试验数据的后分析

期刊:FS Reports
影响因子:2.2
doi:10.1016/j.xfre.2024.06.002
Simon, James A; Stewart, Elizabeth A; Jewell, Susan; Li, Moming; Snabes, Michael C
发表日期：2024
文献求助 收藏

Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial

低促性腺激素男性接受睾酮替代疗法期间的前列腺安全事件：一项随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.48692
Bhasin, Shalender; Travison, Thomas G; Pencina, Karol M; O'Leary, Michael; Cunningham, Glenn R; Lincoff, A Michael; Nissen, Steven E; Lucia, M Scott; Preston, Mark A; Khera, Mohit; Khan, Nader; Snabes, Michael C; Li, Xue; Tangen, Catherine M; Buhr, Kevin A; Thompson, Ian M Jr
免疫/内分泌
发表日期：2023
文献求助 收藏

Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients

在接受elagolix治疗的女性中，子宫内膜异位症相关疼痛的减轻在反映真实世界患者的一系列基线特征中均保持一致。

期刊:BMC Womens Health
影响因子:2.7
doi:10.1186/s12905-021-01385-3
Abrao, Mauricio S; Surrey, Eric; Gordon, Keith; Snabes, Michael C; Wang, Hui; Ijacu, Horia; Taylor, Hugh S
发表日期：2021
文献求助 收藏

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix

接受艾拉戈利治疗的子宫内膜异位症患者的健康相关生活质量改善

期刊:Obstetrics and Gynecology
影响因子:4.7
doi:10.1097/AOG.0000000000003917
Taylor, Hugh S; Soliman, Ahmed M; Johns, Beverly; Pokrzywinski, Robin M; Snabes, Michael; Coyne, Karin S
发表日期：2020
文献求助 收藏

Towards Distributed Recycling with Additive Manufacturing of PET Flake Feedstocks

利用增材制造技术制备PET薄片原料，实现分布式回收

期刊:Materials
影响因子:3.2
doi:10.3390/ma13194273
Little, Helen A; Tanikella, Nagendra G; J Reich, Matthew; Fiedler, Matthew J; Snabes, Samantha L; Pearce, Joshua M
发表日期：2020
文献求助 收藏

JBMR Plus Reviewer List 2020

JBMR Plus 2020 年审稿人名单

期刊:JBMR Plus
影响因子:2.4
doi:10.1002/jbm4.10401
Kilpatrick, Ryan D; Chiuve, Stephanie E; Leslie, William D; Wegrzyn, Lani R; Gao, Wei; Yang, Hongbo; Soliman, Ahmed M; Snabes, Michael C; Koenigsberg, Sarah; Zhong, Jia; Xiang, Cheryl; Watts, Nelson B
发表日期：2020
文献求助 收藏

Fused Particle Fabrication 3-D Printing: Recycled Materials' Optimization and Mechanical Properties

熔融粒子制造3D打印：回收材料的优化及力学性能

期刊:Materials
影响因子:3.2
doi:10.3390/ma11081413
Woern, Aubrey L; Byard, Dennis J; Oakley, Robert B; Fiedler, Matthew J; Snabes, Samantha L; Pearce, Joshua M
3D/类器官
发表日期：2018
文献求助 收藏